Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: Taiwan Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20101
20121
20133
20143
20155
20164
20173
20184
20197
20204
20213
20223
20235
20248
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting22
Completed19
Active, not recruiting10
Terminated9
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Novartis Pharmaceuticals5
AstraZeneca3
Hoffmann-La Roche3
Pierre Fabre Medicament3
DualityBio Inc.2
AP Biosciences Inc.1
AVEO Pharmaceuticals, Inc.1
AbbVie1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung62
Lung Neoplasms12
Neoplasms11
Squamous Cell Carcinoma of Head and Neck11
Melanoma10
Neoplasm Metastasis7
Stomach Neoplasms7
Carcinoma6
Triple Negative Breast Neoplasms6
Breast Neoplasms5

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.